The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma

被引:0
|
作者
Xueying Wang
Junnan Guo
Pingyang Yu
Lunhua Guo
Xionghui Mao
Junrong Wang
Susheng Miao
Ji Sun
机构
[1] Harbin Medical University Cancer Hospital,Department of Head and Neck Tumors
[2] Harbin Medical University Cancer Hospital,The First Department of Colorectal Surgery
关键词
Head and neck squamous cell carcinoma; Extracellular vesicles; EXOs; Tumour microenvironment; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Head and neck squamous cell carcinoma (HNSCC) is one of the main malignant tumours affecting human health, mainly due to delayed diagnosis and high invasiveness. Extracellular vehicles (EVs) are membranous vesicles released by cells into the extracellular matrix that carry important signalling molecules and stably and widely exist in various body fluids, such as plasma, saliva, cerebrospinal fluid, breast milk, urine, semen, lymphatic fluid, synovial fluid, amniotic fluid, and sputum. EVs transport almost all types of bioactive molecules (DNA, mRNAs, microRNAs (miRNAs), proteins, metabolites, and even pharmacological compounds). These “cargoes” can act on recipient cells, reshaping the surrounding microenvironment and altering distant targets, ultimately affecting their biological behaviour. The extensive exploration of EVs has deepened our comprehensive understanding of HNSCC biology. In this review, we not only summarized the effect of HNSCC-derived EVs on the tumour microenvironment but also described the role of microenvironment-derived EVs in HNSCC and discussed how the “mutual dialogue” between the tumour and microenvironment mediates the growth, metastasis, angiogenesis, immune escape, and drug resistance of tumours. Finally, the clinical application of EVS in HNSCC was assessed.
引用
收藏
相关论文
共 50 条
  • [31] EVALUATION OF DRUG TRANSPORTERS' SIGNIFICANCE FOR MULTIDRUG RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Theile, Dirk
    Ketabi-Kiyanvash, Nahal
    Herold-Mende, Christel
    Dyckhoff, Gerhardt
    Efferth, Thomas
    Bertholet, Vincent
    Haefeli, Walter Emil
    Weiss, Johanna
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (07): : 959 - 968
  • [32] Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
    Gougis, Paul
    Bachelard, Camille Moreau
    Kamal, Maud
    Gan, Hui K.
    Borcoman, Edith
    Torossian, Nouritza
    Bieche, Ivan
    Le Tourneau, Christophe
    JNCI CANCER SPECTRUM, 2019, 3 (04)
  • [33] A multilayered epithelial mucosa model of head neck squamous cell carcinoma for analysis of tumor-microenvironment interactions and drug development
    Gronbach, Leonie
    Wolff, Christopher
    Klinghammer, Konrad
    Stellmacher, Johannes
    Jurmeister, Philipp
    Alexiev, Ulrike
    Schafer-Korting, Monika
    Tinhofer, Ingeborg
    Keilholz, Ulrich
    Zoschke, Christian
    BIOMATERIALS, 2020, 258
  • [34] Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival
    Chen, Bojie
    Leung, Leanne Lee
    Qu, Xinyu
    Chan, Jason Ying-Kuen
    CANCERS, 2023, 15 (06)
  • [35] Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma
    Zheng, Yang
    Song, An
    Zhou, Yan
    Zhong, Yi
    Zhang, Wei
    Wang, Chundi
    Ding, Xu
    Du, Yifei
    Zhang, Wei
    Li, Gang
    Wu, Heming
    Wu, Yunong
    Song, Xiaomeng
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2020, 14 (04) : 389 - 402
  • [36] Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma
    Yang Zheng
    An Song
    Yan Zhou
    Yi Zhong
    Wei Zhang
    Chundi Wang
    Xu Ding
    Yifei Du
    Wei Zhang
    Gang Li
    Heming Wu
    Yunong Wu
    Xiaomeng Song
    Journal of Cell Communication and Signaling, 2020, 14 : 389 - 402
  • [37] Docetaxel: An active drug for squamous cell carcinoma of the head and neck
    Dreyfuss, AI
    Clerk, JR
    Norris, CM
    Rossi, RM
    Lucarini, JW
    Busse, PM
    Poulin, MD
    Thornhill, L
    Costello, R
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1672 - 1678
  • [38] DEVELOPMENT OF METHOTREXATE RESISTANCE IN A HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IN CULTURE
    FREI, E
    ROSOWSKY, A
    WRIGHT, JE
    CUCCHI, CA
    LIPPKE, JA
    ERVIN, TJ
    JOLIVET, J
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (09): : 2873 - 2877
  • [39] The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
    F Hakami
    L Darda
    P Stafford
    P Woll
    D W Lambert
    K D Hunter
    British Journal of Cancer, 2014, 111 : 807 - 816
  • [40] The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
    Hakami, F.
    Darda, L.
    Stafford, P.
    Woll, P.
    Lambert, D. W.
    Hunter, K. D.
    BRITISH JOURNAL OF CANCER, 2014, 111 (04) : 807 - 816